Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Touyun Biotech GroupHKSE:01332 -4.79%25 Days Payable is 51.11 as of Dec. 2025, which is 20% below its 10-year median of 63.50. GuruFocus rates HKSE:01332 with a GF Score™ of 25/100 and a GF Value™ of HK$0.16 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 382 Packaging & Containers companies, Touyun Biotech Group ranks better than 56.81% on this metric.
The historical rank and industry rank for Touyun Biotech Group's Days Payable or its related term are showing as below:
HKSE:01332'
s Days Payable Range Over the Past 10 Years
Min: 32.35 Med: 63.5 Max: 92.8
Current: 67.22
During the past 13 years, Touyun Biotech Group's highest Days Payable was 92.80. The lowest was 32.35. And the median was 63.50.
HKSE:01332's Days Payable is ranked better than 56.81% of 382
companies
in the Packaging & Containers industry
Industry Median: 57.265
vs HKSE:01332: 67.22
Touyun Biotech Group's Days Payable
declined
from Dec. 2024 (78.64) to Dec. 2025 (51.11).
It may suggest that Touyun Biotech Groupaccelerated paying its suppliers.
Touyun Biotech Group Days Payable Related Terms
Touyun Biotech Group Days Payable Historical Data
* Premium members only.
The historical data trend for Touyun Biotech Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01332 vs SW, PKG, IP: Days Payable Comparison
For the Packaging & Containers subindustry, Touyun Biotech Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touyun Biotech Group Days Payable vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Touyun Biotech Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Touyun Biotech Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touyun Biotech Group (HKSE:01332) has a Days Payable of 51.11 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Touyun Biotech Group and its competitors. This is 20% below median its historical median of 63.50. Over the past decade, Touyun Biotech Group's Days Payable has ranged from 32.35 to 92.80. According to the industry distribution chart, Touyun Biotech Group ranks #165 out of 382 companies in the Packaging & Containers industry, placing it in the top 43.2%.
Is Touyun Biotech Group's Days Payable too high?
Touyun Biotech Group's current Days Payable of 51.11 is 20% below median its 10-year median of 63.50. Over the past 10 years, this metric has ranged from a low of 32.35 to a high of 92.80. The Packaging & Containers industry median Days Payable is 57.27. Touyun Biotech Group's value of 51.11 is 10.7% below this industry median. Based on the distribution chart, Touyun Biotech Group ranks #165 out of 382 companies in the Packaging & Containers industry, which is above the industry midpoint. Overall, Touyun Biotech Group has a GF Score™ of 25/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's Days Payable compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Touyun Biotech Group ranks #165 out of 382 companies for Days Payable. This puts Touyun Biotech Group in the upper half of its industry. The industry median Days Payable is 57.27. Touyun Biotech Group's value of 51.11 is 10.7% below this benchmark. Historically, Touyun Biotech Group's own Days Payable has ranged from 32.35 to 92.80 over the past decade. While the company's 10-year median is 63.50 vs. the industry median of 57.27, Touyun Biotech Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Packaging & Containers company?
The median Days Payable among Packaging & Containers companies is 57.27, based on 382 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touyun Biotech Group's current Days Payable of 51.11 is 10.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Touyun Biotech Group and its competitors. For the Packaging & Containers industry, the median Days Payable is 57.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touyun Biotech Group's current Days Payable is 51.11, which is 20% below median its own 10-year median of 63.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.14 — trading 13.1% below its estimated fair value. The current Days Payable is 51.11, which is 20% below median its 10-year median of 63.50 and 10.7% below the Packaging & Containers industry median of 57.27. Touyun Biotech Group's overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current Days Payable is 51.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?
Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued.
The current stock price of HK$0.14 is trading 13.1% below its estimated GF Value™ of HK$0.16.
GuruFocus considers Touyun Biotech Group to be Modestly Undervalued.
Key valuation signals for HKSE:01332:
Days Payable: 51.11 (20% below median its 10-year median of 63.50)
GF Value™: HK$0.16 vs. price of HK$0.14 (13.1% below fair value)
Industry Position: 10.7% below the Packaging & Containers median (#165 of 382)
No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
25GF Score
Get the complete analysis for HKSE:01332
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01332 has been successfully added to your 
